
|Articles|September 29, 2016
Rare Tumors Require Different Strategies in Mohs Disease
Aleksandar L. Krunic, MD, PhD, discusses treatment strategies for rare tumor types in Mohs disease during the 25th European Academy of Dermatology and Venereology Congress.
Advertisement
Aleksandar L. Krunic, MD, PhD, dermatologic surgeon and assistant professor of dermatology at University of Illinois College of Medicine, discusses how rare tumors need to be treated differently during therapy for Mohs disease.
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
Enfortumab Vedotin Plus Pembrolizumab Shows Promise as a Platinum-Free Option in Earlier Bladder Cancer
2
FDA Approves Amivantamab and Hyaluronidase-lpuj, Revolutionizing Lung Cancer Treatment With 5-Minute Subcutaneous Delivery
3
Advancing the Role of Pharmacy Technicians in Hazardous Drug Compounding
4
Notable Updates in Medication Therapy Management in 2025
5









































































































































































































